Risk Characterization

Similar documents
WHO Human Health Risk Assessment Toolkit: Chemical Hazards

1, 2, 3-Trichloropropane (TCP): Assessment of Risks from Drinking Water

6.3.5 Uncertainty Assessment

Presenting Uncertainty in the Context of Toxicological, Biological Monitoring and Exposure Information. William H.

HEALTH CONSULTATION. Tom Lea Park EL PASO COUNTY METAL SURVEY EL PASO, EL PASO COUNTY, TEXAS EPA FACILITY ID: TX

Pizza Pan Case Study

CHAPTER 8 RISK CHARACTERIZATION

Risk Assessment Report for AGSS-ICS

Baseline Human Health Risk Assessment. Terrie Boguski, Skeo Solutions

Outline: risk assessment. What kind of environmental risks do we commonly consider? 11/19/2013. Why do we need chemical risk assessment?

Methodologies for development of human health criteria and values for the lake Erie drainage basin.

Poly-fluoroalkyl substances (PFASs), also called perfluoroalkyl substances (PFASs)

STUDIES TO EVALUATE THE SAFETY OF RESIDUES OF VETERINARY DRUGS IN HUMAN FOOD: GENERAL APPROACH TO ESTABLISH AN ACUTE REFERENCE DOSE

Development of NJ Human Health-based Criteria and Standards

Rethinking Approaches To Low Dose Extrapolation for Environmental Health Risk Assessment

Part 2. Chemical and physical aspects

Sudbury Human Health Risk Assessment Briefing

SUDBURY AREA RISK ASSESSMENT VOLUME II EXECUTIVE SUMMARY

Thought Starter Combined Exposures to Multiple Chemicals Second International Conference on Risk Assessment

Risk assessment for redevelopment of contaminated land at an old industrial site

Chapter 6 Quantifying Exposure

Prelude to Risk Characterization Exposure Calculations from Risk and Decision Making

APPENDIX IV.I.1. Delivery Truck HRA

Screening Level Health Risk Assessment of PCCD/PCDF Contamination Da Nang Airbase Case Study

Glyphosate and Cancer Risk. Jeffrey Jenkins, Ph.D. Department of Environmental and Molecular Toxicology Oregon State University

Quantitative Risk Assessment: An Overview and Discussion of Emerging Issues. Anne-Marie Nicol, PhD

5.0 HAZARD ASSESSMENT AND RISK CHARACTERIZATION

Approaches to Integrating Evidence From Animal and Human Studies in Chemical Assessments

Risk Assessment and 09/13/07. Learning Objectives. Nature of Risk. Risk Assessment and Environmental Policy. Gene Schroder, PhD

CHAPTER 2: RISK ANALYSIS

Risk Assessment Issues: Asbestos p. 100 Review of Epidemiological Evidence for Health Effects in Workers Exposed to MMMFs p. 103


RISK ASSESSMENT GUIDANCE FOR SUPPLEMENTAL GUIDANCE FOR INHALATION RISK ASSESSMENT SUPERFUND, PART F: Midwestern States Risk Assessment

Evaluating Methods for Quantifying Human Noncancer Health Risks: Case Study Application. Contract # EP-W (Work Assignment #77) REVISED DRAFT

Arkansas Department of Health

MINNESOTA DEPARTMENT OF HEALTH STATEMENT OF NEED AND REASONABLENESS

Dose and Response for Chemicals

DEVELOPMENT OF THE CHROMIUM PUBLIC HEALTH GOAL

CHAPTER 7 TOXICITY ASSESSMENT

Premarket Review. FFDCA Section 201(s) FFDCA Section 201(s) (cont.)

ENV 455 Hazardous Waste Management

US power plant carbon standards and clean air and health co-benefits

Appendix 9.2.2A Human Health and Ecological Risk Assessment

AECOM Environment Figures January 2010

Health Consultation. Apple Trees Recreational Area (PICA Site 192) PICATINNY ARSENAL ROCKAWAY TOWNSHIP, MORRIS COUNTY, NEW JERSEY

Protocol 30 Classifying Substances as Carcinogenic May 2018

Ethylene Oxide

Methodology for Developing Chemical Exposure Guidelines for Deployed Military Personnel

Oregon Department of Human Services. 800 NE Oregon Street #604 (971) (971) TTY-Nonvoice TECHNICAL BULLETIN

Human Health Risk Assessment Overview [For the APS/OPP Roundtable]

HSIA Halogenated Solvents Industry Alliance, Inc.

and Benchmark Toxicology Services HEALTH RISK ASSESSMENT OF ATMOSPHERIC EMISSIONS EXPANSION OF WAGERUP REFINERY TO 4.7 MTPA

Asthma and air pollution: health effects and prevention

Uncertainties in Dietary Exposure Analysis A Challenge to Be Addressed

Which delivers more mercury, dental amalgam or a tuna fish sandwich? G. Mark Richardson, Ph.D. Risklogic Scientific Services Inc., Ottawa, ON CANADA

Evaluation of Mixture Exposures in Human Health Risk Assessments. Ruth Custance, MPH

Texas Commission on Environmental Quality

Probabilistic Risk-Cost-Benefit Analysis of Additional Benzene Emissions Controls

Case Study Application of the WHO Framework for Combined Exposures. Presented by: M.E. (Bette) Meek University of Ottawa

Chapter 6 Physical and chemical quality of drinking water

APPENDIX G: TECHNICAL BASIS FOR PRELIMINARY REMEDIATION GOALS FOR FISH TISSUE IN ONONDAGA LAKE HONEYWELL

Risk management of mycotoxin presence in food products:major unsolved points

Science Policy Notice

cccta 17ème Journées Scientifiques, Les Diablerets VD

Chemical Risk Assessment and Translation to Socio-Economic Assessments

APPLICATION FOR AUTHORISATION: ESTABLISHING A REFERENCE DOSE RESPONSE RELATIONSHIP FOR CARCINOGENICITY OF INORGANIC ARSENIC COMPOUNDS

Chemical Name: Metolachlor ESA CAS: Synonyms: Ethanesulfonate degradate of metolachlor; CGA

Hazard, exposure, and risk Thinking about risk Risk assessment processes Risk management A.001 Environmental Engineering 2

What are the challenges in addressing adjustments for data uncertainty?

How to Explain Radiation Risk

ANNEX 5 CONSUMER PRODUCT LABELLING BASED ON THE LIKELIHOOD OF INJURY

Environmental Risk Assessment Toxicity Assessment

The regulatory landscape. The now and the not yet

Risk Assessment Terminology, Expression of Nature and level of Risk and Uncertainties

Mandates of the FQPA. ES/RP 532 Applied Environmental Toxicology. Tolerance. Mandate of FIFRA. FQPA Mandate. How Tolerance Is Developed

Subject: Assessing the Potential Risk of Human Exposure to Tetrachloroethylene (Perchloroethylene) and Formaldehyde

How to estimate the health impact for restriction process with a special focus on estimation of the number of exposed people

Toxicological Intake Values for Priority Contaminants in Soil

Topic 3.13 Use of NOAEL, benchmark dose, and other models for human risk assessment of hormonally active substances*,

The Director General Maisons-Alfort, 30 July 2018 OPINION. of the French Agency for Food, Environmental and Occupational Health & Safety

Mathematical Framework for Health Risk Assessment

Assessing and Managing Health Risks from Chemical Constituents and Contaminants of Food

Appendix A - Human Health Risk Assessment

Assessing Risks of Exposure to Allergens from Foods

Key Aspects of U.S. EPA s External Review Draft Toxicological Review of Trichloroethylene (TCE)

Human Health Risk Assessment. Marian Olsen U.S. EPA ERRD October 13, 2011

Special Review Decision: Imazapyr

INITIAL STATEMENT OF REASONS TITLE 27, CALIFORNIA CODE OF REGULATIONS

Public health and chronic low chlordecone exposures in Guadeloupe; Part 2: Health impacts, and benefits of prevention

EXCERPT FROM MERCURY STUDY REPORT TO CONGRESS VOLUME I: EXECUTIVE SUMMARY

Regulatory Toxicology and Pharmacology

Evaluation of Potential Human Health Effects from Environmental Exposure to Human Pharmaceuticals

Chemical Name: Metolachlor OXA CAS: Synonyms: Oxanilic acid degradate of metolachlor

Current status of Benchmark Dose Modeling for 3-Monochloropropane-1,2-diol (3-MCPD)

OPINION of the French Agency for Environmental and Occupational Health Safety

Tetrachloroethylene: Integrated Risk Information System (IRIS) Draft Toxicological Review Kate Z. Guyton, PhD DABT

1,4-Dioxane: Overview & NJDEP Ground Water Quality Criterion

Health Impact Assessment following HRAPIE

Burden of Mortality and Disease Attributable to Multiple Air Pollutants in Warsaw, Poland

Application of the WHO Framework for Combined Exposures; Implications for Combined Exposures Assessment

Transcription:

Risk Characterization 1

Learning Objectives By the end of this module, participants should have an understanding of: The purpose of risk characterization Integrating the results of hazard identification, hazard characterization, and exposure assessment Common metrics used to describe risk Approaches for discussing uncertainties, assumptions, and scientific judgments 2

Key Messages Risk characterization, the last step in a risk assessment, is a qualitative or quantitative statement about the likelihood of harm associated with exposure to an agent including the identification and consideration of attendant uncertainties. Likelihood of harm is determined by combining results of the hazard characterization step and the exposure assessment step. Frequently used quantitative measures of risk are the hazard index, excess lifetime cancer risk, and margin of exposure. Risk can also be characterized quantitatively by comparing exposure concentrations for an agent in an environmental medium to corresponding guideline values derived from authoritative organizations such as the World Health Organization and national agencies The output of risk characterization should be presented in a manner that ensures that the risk manager and risk communicator understand the biological meaning and uncertainties of the risk assessment and how 3 these can impact on their responsibilities.

Mechanistic basis for the sequence of events in the environmental health paradigm Environmental health paradigm Risk assessment framework Biological, chemical, physical and social determinants of the critical events leading from release of toxic agents into the environment to resulting disease or injury in people or the environment Pollutant transport, transformation and fate processes Demographic, geographic, lifestyle and ecological attributes Pharmacokinetics 1 Pharmacodynamics 2 1 Pharmacokinetics - what the body does to the agent 2 Pharmacodynamics - what the agent does to the body Emission source(s) Environmental concentrations Exposure Internal dose Adverse effect(s) Exposure assessment What environmental exposures are expected to occur, and what is the resulting dose to target tissue? Hazard characterization What is the relationship between dose to the target tissue and adverse effects? Hazard identification Is the environmental agent capable of causing an adverse effect? Risk characterization What is the estimated risk from anticipated exposure? 4

Risk = Hazard x Exposure Risk Characterization-The qualitative and, wherever possible, quantitative determination, including attendant uncertainties, of the probability of occurrence of known and potential adverse effects of an agent in a given organism, system, or (sub)population, under defined exposure conditions Risk= Hazard x Exposure 5

Major Components of Risk Characterization State the objective of the assessment Quantitative or qualitative statement of likelihood of harm Discussion Assumptions and uncertainties Identify alternative interpretations Distinguish scientific conclusions from policy judgments 6

Statement of Objective What population has the potential to be at risk? What is the time period of concern? Where is the exposure located and through what media? What is the agent(s) of concern? What are the health effects of concern? 7

State Likelihood of Harm Typically a probabilistic statement based upon comparing the amount of exposure to applicable benchmarks Examples of risk statements from various countries (YY to be filled in) 8

Applicable Benchmarks Conventions for de minimus or acceptable risk Health protective guidance levels Guideline levels for concentrations of chemicals in specific media, such as air, water, soil, sediment, and food Normative levels such as concentrations and exposures that are typical and presumably tolerated or accepted Sources: international and national organizations; scientific literature 9

Roadmap for Risk Characterization Review the objective of the assessment Compare to guidance value Obtain the guidance value Calculate the hazard index: exposure concentration or rate divided by guidance value Does the assessment question require comparison to a guidance or calculation of cancer risk? Obtain the exposure metric derived from the exposure assessment Calculate cancer risk Obtain the cancer slope factor for the chemical (CSF) Calculate excess lifetime cancer risk: product of exposure metric and CSF Is exposure less than, equal to, or greater than guideline? Is ELCR in the range of acceptable risk? Source: WHO Toolkit for Human Health Risk Assessment: Chemical Hazards Report results to risk management team 10

Conventions for de minimus Risk Convention Human, Non-Cancer Exposure rate below threshold for adverse effect Human, Cancer Probability of a tumor is acceptably low Ecological Exposure concentration below threshold for adverse effect 11

Health Protective Guidance Levels Convention Human, Non-Cancer Exposure below threshold for adverse effect Human, Cancer Probability of a tumor is acceptably low Ecological Exposure concentration below threshold for adverse effect Hazard Characterization Input ADI, TDI, RfD, RfC, BMD, etc. Cancer slope factor (CSF) Predicted No Effect Concentration (PNEC) Exposure Input Period average daily dose (PADD) Lifetime average daily dose (LADD) Predicted environmental concentration (PEC) Risk Metric Hazard quotient (HQ) Excess lifetime cancer risk (ELCR) Hazard quotient (HQ) Calculation HQ = PADD/ADI (or other) ELCR = LADD x CSF HQ = PEC/PNEC 12

Characterization of Non-Cancer Risk Hazard Quotient (HQ) A metric for evaluating the risk associated with exposure to chemicals that may cause (noncancer) effects Hazard Quotient = Average Daily Dose Guidance Value Calculated as the ratio of average daily to a guideline value Guideline values for a wide range of chemicals are available from international and national resources (refer to the Hazard Characterization section of the workshop) HQ < 1 HQ > 1 The chemical exposure is less than the benchmark; unlikely to result in adverse effect The exposure is greater than the benchmark; potential risk 13

Example: Hazard Quotient Recall our example of period average exposure to arsenic in drinking water that was presented in the exposure section of the workshop Hazard Quotient = Average Daily Dose Guidance Value Objective: characterize the risk of systemic effects to human health associated with that exposure FAO/WHO Benchmark Hazard Quotient = 0.2 µg/kg/d 2 µg/kg/d Average Daily Dose: 0.2 micrograms of arsenic per kilogram body weight per day Guidance values 2 µg/kg/d Joint FAO/WHO Expert Committee on Food Additives 0.3 µg/kg/d U.S. Environmental Protection Agency EPA Benchmark Hazard Quotient = = 0.1 HQ less than 1 0.2 µg/kg/d 0.3 µg/kg/d = 0.67 HQ less than 1 14

Characterization of Cancer Risk Excess lifetime cancer risk (ELCR) A metric for quantifying risk associated with exposure to chemicals that may cause cancer Calculated as the product of dose and the cancer slope factor Information on carcinogenicity of chemicals is available from international and national resources (refer to the Hazard Characterization section of the workshop) ELCR = ELCR < 10-6 ELCR > 10-4 Lifetime Average Daily Dose x Cancer Slope Factor Excess lifetime cancer risk less than 1 in a million is typically considered de minimus or negligible Excess lifetime cancer risk greater than 1 in ten thousand is a common benchmark for gathering additional information or relaxing conservative assumptions that may be used in a screening analysis 15

Example: Excess Lifetime Cancer Risk Recall our example of period average exposure to arsenic in drinking water that was presented in the exposure section of the workshop Objective: characterize the risk of systemic effects to human health associated with that exposure Lifetime Average Daily Dose: 0.09 micrograms of arsenic per kilogram body weight per day Guidance values 1.5 per mg/kg/d - U.S. Environmental Protection Agency ELCR = Lifetime Average Daily Dose x Cancer Slope Factor = 0.09 ug/kg/d x 1 mg/10 3 ug x 1.5 per mg/kg/d = 1.35 X 10-4 The extra risk of cancer associated with lifetime exposure to arsenic in drinking water is 1.35 in 10,000 or approximately 0.01% 16

Characterization of Ecological Risk Hazard Quotient= PEC/PNEC HQ < 1 No immediate concern HQ = 1-10 Of concern if supply volumes increase HQ= 10-100 Further data require HQ > 100 Reduce risk immediately

Media-Specific Chemical Concentrations as Benchmarks Guidance values for non-cancer effects; slope factors for cancer Health protective concentrations for chemicals in environmental media are backcalculated from conventions for acceptable levels of risk; guidance values for adverse effects, exposure factors and exposure from other pathways or media. Guideline values for chemicals in air, water, food, soil Intake rates for environmental media: air, water, food, soil Exposure Benchmarks Exposure Factors Concentration Benchmarks 18

Types of Media-Specific Guideline Values Type of Benchmark Type of Effect Benchmark Description of the Benchmark Units Note Source Media-specific Concentrations Non-cancer and cancer. Benchmark value is the lower of the two concentrations that yield exposure equivalent to the non-cancer or cancer risk convention for acceptable risk Air quality guidelines Ambient air quality standards Drinking water quality guidelines Maximum Contaminant Levels for drinking water Risk-based concentrations An estimate of the concentration of selected pollutants in outdoor air that is intended to be health protective; separate values for different averaging times An estimate of the concentration of contaminants in drinking water that is intended to be health protective An estimate of the concentration of contaminants in air, water, and soil that is intended to be health protective µg/m 3 or ppb mg/l, µg/l, ppm, ppb Various Particulate matter, sulfur dioxide, nitrogen dioxide, carbon monoxide, ozone and lead Considers intake from other media Considers intake from drinking water only Large number of contaminants considered; values do not consider intake from other media WHO USEPA and others WHO USEPA and others USEPA and others 19

Example of Media-Specific Guideline Values 1 2. Contact Rate Variability: Water consumption Inhalation Food consumption Dermal contact 3. Exposure Rate Variability: Natural sources Cultural practices Lifestyle choices 20

Normative Levels as Benchmarks Concentrations and exposures that are typical and presumably tolerated or accepted An approach for providing context to quantitative estimates of exposure and risk Information on normative levels is available from international and national resources WHO Environmental Health Criteria series WHO CICAD series 21

Example of Normative Levels Standard radiation dose from clearance level Source: Japan Ministry of Education, Culture, Sports, Science and Technology 22

Discussion Risk characterization should include an evaluation of the overall quality of the assessment Fair and open presentation of the uncertainties in the calculations and a characterization of how reliable (or how unreliable) the resulting risk estimates really are Describe the degree of confidence the assessors have in the estimates and conclusions identify the strengths and uncertainties of the risk assessment Quality and quantify of available data Gaps in the data on exposure or dose-response Understanding of biological mechanisms Scientific judgments that were used to bridge gaps in information Types of uncertainties and assumptions typically addressed in risk characterization Agreement between animal toxicology and human studies that address dose-response relationships Realism of exposure scenarios Whether the assumptions made are likely to overestimate or underestimate risk 23

International Resources 24

Key Messages Risk characterization, the last step in a risk assessment, is a qualitative or quantitative statement about the likelihood of harm associated with exposure to an agent including the identification and consideration of attendant uncertainties. Likelihood of harm is determined by combining results of the hazard characterization step and the exposure assessment step. Frequently used quantitative measures of risk are the hazard index, excess lifetime cancer risk, and margin of exposure. Risk can also be characterized quantitatively by comparing exposure concentrations for an agent in an environmental medium to corresponding guideline values derived from authoritative organizations such as the World Health Organization and national agencies The output of risk characterization should be presented in a manner that ensures that the risk manager and risk communicator understand the biological meaning and uncertainties of the risk assessment and how 25 these can impact on their responsibilities.